Previous 10 | Next 10 |
Rosh Pina, Israel, Aug. 21, 2023 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive AI-driven infrared spectrographic analysis technology platform to address significant healthcare needs, today issued the following upd...
IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 2024 2.5 mil lion patients develop pressure injuries and 60,000 die annually as a direct result ; $26.8 bil ...
Early detection of pressure injuries can be challenging for minority populations due to the current method of visual inspection P atients with dark skin tones suffered more than twice as much as those with lighter skin, e viden...
Innovative executive driving positive outcomes and profitability , Dr. Eschenbacher is focus ed on addressing healthcare access and equity Through early, non-invasive detection of pressure injuries, PressureSafe i...
A 94.7% accuracy in identifying Stage 1 pressure injuries was achieved in a proof-of-concept device upon which PressureSafe is based C ompany to exhibit and demo its “sense the invisible” handheld medical device set to transform pressure injury detect...
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the “Company”) ( OTCQB:IRME ) , will be ...
The study will expand to Rabin Medical Center (RMC), in parallel to Beit-Rivka, turning the study to a double c enter usability study. Rosh Pinna, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- (“ IR-MED or the “ Company ”) ( OTCQB:IRME) , an ...
IR-Med Gains Momentum in 2022 PR Newswire Biotech company makes significant progress on its PressureSafe device, teeing up entry into U.S. market in 2023 ROSH PINNA , Israel , Feb. 8, 2023 /PRNewswire/ -- " IR-MED" or the "Company" (OTCQB:IRME...
Dr. Dalton brings decades of experience as a hall of fame CEO, entrepreneur, pharmaceutical executive and founder of over 40 companies Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) -- " IR-MED ” or the " Company ") (OTCQB...
Rosh Pinna, Israel, Aug. 30, 2022 (GLOBE NEWSWIRE) -- (“ IR-MED or the “ Company ”) ( OTCQB: IRME) , an innovative medical device company that is developing non-invasive, real-time detection devices utilizing Infra-Red light spectroscopy (IR) and Artific...
News, Short Squeeze, Breakout and More Instantly...
IR-Med Inc Company Name:
IRME Stock Symbol:
OTCMKTS Market:
By Thomas Kerr, CFA IR-Med (OTC: IRME) released its annual 10-K filing on April 1, 2024 and the results were largely in line with expectations. The...
Marks major milestone prior to launch in U.S. market PressureSafe ™ s canner and disposable pack both listed with FDA PressureSafe ™ can support early detection of pressure injuri...
Incidence of pressure injuries reduced by 50% during the study period As a decision support device, PressureSafe, can support early detection of pressure injuries, potentially setting a new standard of care to address a healthcare challenge that costs $26.8 billion annually in the U.S...